FindTrial
Sign In

prospective observational study to assess efficacy and safety of nivolumab in patients with recurrent non-small cell lung cancer

prospective observational study to assess efficacy and safety of nivolumab in patients with recurrent non-small cell lung cancer - prospective observational study to assess efficacy and safety of nivolumab in patients with recurrent non-small cell lung cancer

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000023210
Enrollment
200
Registered
2016-07-19
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

None listed

Sponsors

Gunma University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)adequate patients to administrate nivolmab, after 1st line chemotherapy 2)patients who assent to this study

Exclusion criteria

Exclusion criteria: 1)inadequate patients to administrate nivolmab 2)patients that the investigators identify inadequate for this study

Design outcomes

Primary

MeasureTime frame
response rate and their clinical profiling—

Countries

Japan

Contacts

Public ContactShinsuke Kitahara

Gunma University Hospital department of respiratory and allergy medicine

shinkita.s50@gmail.com027-220-7111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026